Please Wait
Applying Filters...
menu
    • menu
    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    Virtual Booth

    Contact Supplier

    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Brilaroxazine

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Reviva to Present Brilaroxazine Speech Data at CNS Summit 2024
    Reviva to Present Brilaroxazine Speech Data at CNS Summit 2024

    06 Nov 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/11/06/2975650/0/en/Reviva-to-Present-Positive-Speech-Latency-Data-for-Brilaroxazine-in-Schizophrenia-From-the-Phase-3-RECOVER-Trial-at-the-CNS-Summit-2024.html

    GLOBENEWSWIRE
    06 Nov 2024
    Share Share
    Reviva Pharmaceuticals To Participate In Lytham Conference
    Reviva Pharmaceuticals To Participate In Lytham Conference

    26 Sep 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/09/26/2953812/0/en/Reviva-Pharmaceuticals-to-Participate-in-the-Lytham-Partners-Fall-2024-Investor-Conference.html

    GLOBENEWSWIRE
    26 Sep 2024
    Share Share
    Reviva Announces New Vocal Biomarker Data
    Reviva Announces New Vocal Biomarker Data

    09 Sep 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/09/09/2942764/0/en/Reviva-Announces-New-Vocal-Biomarker-Data-from-Phase-3-RECOVER-Trial-of-Brilaroxazine-in-Schizophrenia.html

    GLOBENEWSWIRE
    09 Sep 2024
    Share Share
    Reviva To Join H.C. Wainwright Investment Conference
    Reviva To Join H.C. Wainwright Investment Conference

    04 Sep 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/09/04/2940452/0/en/Reviva-to-Participate-in-the-H-C-Wainwright-26th-Annual-Global-Investment-Conference.html

    GLOBENEWSWIRE
    04 Sep 2024
    Share Share
    Reviva To Host KOL Event On Brilaroxazine Vocal Biomarker Data
    Reviva To Host KOL Event On Brilaroxazine Vocal Biomarker Data

    27 Aug 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/08/27/2936186/0/en/Reviva-to-Host-Virtual-KOL-Event-to-Discuss-Vocal-Biomarker-Data-from-Phase-3-RECOVER-Trial-of-Brilaroxazine-in-Schizophrenia-on-September-4-2024.html

    GLOBENEWSWIRE
    27 Aug 2024
    Share Share
    Reviva Gets US Patent For Brilaroxazine In Pulmonary Fibrosis
    Reviva Gets US Patent For Brilaroxazine In Pulmonary Fibrosis

    06 Aug 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/08/06/2925011/0/en/Reviva-Announces-Grant-of-U-S-Patent-Covering-Use-of-Brilaroxazine-for-the-Treatment-of-Idiopathic-Pulmonary-Fibrosis.html

    GLOBENEWSWIRE
    06 Aug 2024
    Share Share